UT18™ Stem Cell GPS™ Platform
Regeneration – Made in Your Body
Utopia Therapeutics
Platform Overview
• Proprietary endogenous repair activation platform
– Mobilizes repair-competent cells to stressed tissue
– No external stem cell transplantation
– Scalable across nutraceutical, cosmeceutical, and regulated therapeutics
– Built on Utopia’s proprietary discovery engine
Scientific Validation
• Demonstrated selective cell migration in vitro
– Validated in preclinical gut, wound, and tissue stress models
– Consistent safety observations across studies
– Selectivity for regenerative cells over inflammatory cells
Intellectual Property Portfolio
• Composition of matter filings
– Methods of use in tissue regeneration
– Applications: gut repair, dermal repair, mucosal healing
– Stroke and neuro-recovery indications
– Formulation and delivery innovations
– US and international filings; multiple divisional applications
NexaGut™
• Indication: IBS and gut barrier support
– Supports epithelial recovery and mucosal integrity
– Consumer rollout underway in India
– Platform expansion potential
NexaSweet™
• Indication: Gut–Liver–Metabolic axis support
– Regenerative positioning with metabolic support
– Retail and e-commerce expansion planned
NexaDerm™ (Planned)
• Indication: Skin rejuvenation and dermal recovery
– Topical regenerative cosmeceutical
– Target launch: 2027
Pipeline Expansion
• NexaRecover™ – Alcohol-related tissue stress recovery
– GingivaReg™ – Oral mucosal repair
– Expansion into regulated neuro and tissue injury indications
Commercial Strategy
• Hybrid model: consumer → clinical → regulated therapeutics
– Near-term revenue from nutraceutical vertical
– Long-term licensing opportunities
– Multi-indication expansion from single IP backbone
Platform Vision
• Enable scalable regenerative support
– Activate the body’s intrinsic repair capacity
– Build a global multi-indication regenerative platform
Enjoy a FREE Consultation on your first visit! Let our expert team help you achieve a healthier, more confident smile.
